Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Columnist Mary Shaniqua, returning from her post-wedding activities, has learned that stepping back from advocacy obligations ...

The stroke rate among adults and children with sickle cell disease in the U.S. is rising, indicating a need for greater ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help advance her work on programs for sickle cell disease (SCD) in her home country.

The U.S. Food and Drug Administration (FDA) gave the greenlight for Iomab-ACT, a potentially less toxic conditioning regimen, to be tested in people with sickle cell disease (SCD) undergoing a stem ...

The women's sorority plans to donate $2 million by 2028 to St. Jude Children's Research Hospital, which offers care at no ...